Stocks/APD

APD three-lens brief

Evidence-based stock research on APD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$229.11$315.18$324.00

Performance

1W
-1.2%
1M
+11.0%
3M
+3.2%
6M
+5.3%
YTD
+27.6%
1Y
+20.5%
3Y
—
5Y
—
APD · Nightly brief
Inspect

50-day MA above 200-day MA (golden-cross regime); price above both. · Trading at 91% of its 52-week range — near the top of the band.

  • Trading at 91% of its 52-week range — near the top of the band.
  • 50-day MA above 200-day MA (golden-cross regime); price above both.
  • Outperforming SPY by 13.7pp over 30 days.
  • P/E of 132 — priced for high growth; little margin of safety.
  • Negative free cash flow last quarterly (-$187.96M).

APD closed at $315.18 (+0.94%) as of 2026-11-12. Market cap: $70.19B. P/E (trailing) 131.9. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 13.7pp over 30 days.. Concerns: trading at 91% of its 52-week range — near the top of the band.; p/E of 132 — priced for high growth; little margin of safety.. Last quarter: Revenue $3.56B, net income $584.30M, free cash flow -$187.96M.

Market ✓· Fundamentals ✓· 1 events
Informational only · Not investment advice
Three-lens method

Why three lenses on APD, not one.

A single reasoning model has blind spots it doesn’t know about. We examine APD across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/APD"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath APD brief"></iframe>